表紙
市場調查報告書

全球細胞診斷市場預測:2022年

Global Tissue Diagnostics Market, Forecast to 2022

出版商 Frost & Sullivan 商品編碼 643502
出版日期 內容資訊 英文 179 Pages
商品交期: 最快1-2個工作天內
價格
全球細胞診斷市場預測:2022年 Global Tissue Diagnostics Market, Forecast to 2022
出版日期: 2018年05月10日內容資訊: 英文 179 Pages
簡介

本報告提供全球細胞診斷市場相關調查,美國,西歐,APAC (亞太地區) 、以及其他 (ROW)的未來展望分析,成長機會,業者情勢,競爭情形的特徵,市場結構的轉變,及主要課題等相關分析。

第1章 摘要整理

第2章 市場概要

第3章 市場成長促進要素與阻礙因素

第4章 市場預測

  • 市場工程檢測
  • 全球收益預測
  • 全球收益預測的討論
  • 全球收益預測:各市場區隔
  • 全球收益預測:各市場區隔的討論
  • APLIS的未來的需求、市場動態
  • 收益比預測:各地區
  • 收益預測:各地區

第5章 競爭環境

  • 全球市場佔有率分析
  • 主要的競爭企業
  • 細胞診斷市場參與企業的策略
  • 全球市場參與企業矩陣
  • 競爭企業的市場區隔排行榜矩陣
  • 細胞診斷排行榜
  • 關注的活動

第6章 成長機會

  • 成長機會1:搭配診斷 (CDx) 牽引先進染色技術
  • 成長機會2:工作流程轉移至整合型組織病理系統
  • 成長機會3:效率改善的分子、病理學工作流程的轉換
  • 成長機會4:細胞診斷的自動化 & 數位化的需求高漲

第7章 美國

  • 地區概要
  • 主要調查結果
  • 收益預測
  • 收益預測:各市場區隔
  • 收益預測的討論
  • 國家分析
  • 市場佔有率分析
  • 病理學必要條件的變化
  • 採用了細胞診斷技術的搭配診斷 (CDx)
  • CDx組合產品相關使用PCR & NGS 的細胞診斷技術的行銷比率比較
  • 組合產品相關PCR & NGS 使用的細胞診斷技術的行銷比率比較
  • 細胞、搭配診斷的夥伴關係
  • 資本價格分析
  • 銷售管道分析
  • 服務供應商分析
  • APLIS的競爭情形
  • 關注企業

第8章 西歐

第9章 APAC (亞太地區)

第10章 其他 (ROW)

第11章 總論

第12章 附錄

目錄
Product Code: K25A-55

Liquid Biopsy for Therapy Monitoring and Reimbursement Cuts Impede Long-term Prospects of Tissue Diagnostics Market

Tissue diagnostic techniques are used to recognize specific antigens in preserved tissues. The process includes slicing thin tissue samples that are treated with a hematoxylin and eosin (H&E) stain, and then are formalin-fixed paraffin-embedded (FFPE) to diagnose tumors and other histopathology specimens. This has traditionally required skilled pathologists and is one of the most labor-intensive and time-consuming processes of clinical molecular diagnostic testing. It is estimated that 70% of the workflow in a histology laboratory is manual, and therefore, there is a need for automation.

The current challenges faced by the industry include shortage of qualified pathologists, consolidation of laboratories leading to shrinkage of the customer base, reimbursement cuts, and competition from novel technologies such as liquid biopsy and next generation sequencing. To address these challenges, vendors have resorted to technology innovation for automation, partnerships with pharmaceutical companies (for companion diagnostics), and information management system (to offer end-to-end solutions) to deepen solution expertise while catering to changing customer demands. Furthermore, the industry is also witnessing collaborations and M&As such as StatLab Medical Products with American MasterTech Scientific.

Research Scope:

The key objectives of the market engineering for tissue diagnostics study are to highlight current market dynamics, key market participants, customer segments, and evolving business opportunities. The study aims to identify both established enterprises and startups, which are capable of shaping the future through best practices implementation, visionary leadership, and innovation in product offerings. Further, the study provides an analysis of market sizing by revenue segregated by pre-analytical staining, advanced staining, and anatomic pathology laboratory information systems. It covers the key drivers, challenges in the market impeding growth, competitive landscape, market participant strategies, reimbursement scenario, capital pricing, and future growth strategies. The study also highlights growth opportunities, key trends, mergers and acquisitions, notable partnerships, investment, and collaboration opportunities across regions such as the United States, Western Europe, Asia-Pacific, and Rest of the World (ROW).

Major participants mentioned in the study are Roche (Ventana), Leica Biosystems, Agilent (Dako), Sakura, Thermo Fisher Scientific, Biocare Medical, Abbott, Epic Systems, Cerner, NovoPath, and Sunquest, Xifin.

Key Issues Addressed:

  • What is the future outlook of tissue diagnostics market in the US, Western Europe, APAC, and Rest of the World?
  • What are the growth opportunities in tissue diagnostics space which can be leveraged by existing and future participants?
  • What constitutes a complete tissue diagnostics vendor landscape? How has the competitive landscape been characterized? Which vendors are dominating the market?
  • How will the structure of the market change over time? Is it ripe for acquisitions?
  • What are the key challenges that affect the uptake of automated systems in the US, Western Europe, APAC, and ROW?

Table of Contents

1. EXECUTIVE SUMMARY

  • Key Findings
  • Key Findings (continued)
  • Market Engineering Measurements
  • Scope and Segmentation
  • Key Questions this Study will Answer
  • Strategic Imperatives for the Tissue Diagnostics Market
  • 6 Big Growth Themes for Tissue Diagnostics Market
  • Future Trends-Three Big Predictions Driving Tissue Diagnostics Market

2. MARKET OVERVIEW

  • Market Background
  • Market Segmentation
  • Trends in Tissue Diagnostics Market
  • Trends in Tissue Diagnostics Market (continued)
  • Trends in Tissue Diagnostics Market (continued)
  • Future of Pathology Laboratory
  • Regional Trends in Pathology Market
  • Regional Trends in Pathology Market (continued)

3. MARKET DRIVERS AND RESTRAINTS

  • Market Drivers
  • Market Restraints

4. MARKET FORECAST

  • Market Engineering Measurements
  • Global Revenue Forecast
  • Global Revenue Forecast Discussion
  • Global Revenue Forecast by Segment
  • Global Revenue Forecast by Segment Discussion
  • Future Demand and Market Dynamics for APLIS
  • Percent Revenue Forecast by Region
  • Revenue Forecast by Region

5. COMPETITIVE ENVIRONMENT

  • Global Market Share Analysis
  • Top Competitors
  • Tissue Diagnostics Market Participant Strategies
  • Tissue Diagnostics Market Participant Strategies (continued)
  • Tissue Diagnostics Market Participant Strategies (continued)
  • Global Competitor Matrix
  • Global Competitor Matrix (continued)
  • Global Competitor Matrix (continued)
  • Global Competitor Matrix (continued)
  • Global Competitor Matrix (continued)
  • Global Competitor Matrix (continued)
  • Competitor Segment Ranking Matrix
  • Tissue Diagnostics Leaderboard
  • Notable Activities
  • Notable Activities (continued)
  • Notable Activities (continued)
  • Notable Activities (continued)
  • Notable Activities (continued)
  • Notable Activities (continued)

6. GROWTH OPPORTUNITIES

  • Growth Opportunity 1-Companion Diagnostics (CDx) to Drive Advanced Staining Techniques
  • Growth Opportunity 2-Workflow Shift Towards Integrated Histopathology Systems
  • Growth Opportunity 3-Converging Molecular and Pathology Workflow for Enhanced Efficiency
  • Growth Opportunity 4-Increasing Need for Automation & Digitization in Tissue Diagnostics

7. UNITED STATES

  • US Regional Snapshot
  • US Key Findings
  • US Revenue Forecast
  • US Revenue Forecast by Segment
  • US Revenue Forecast Discussion
  • US Country Analysis
  • US Market Share Analysis
  • US Market Share Analysis (continued)
  • US Changes to Pathology Reimbursement
  • CDx using Tissue Diagnostics Techniques
  • Comparison between Rate of Marketing of Tissue Diagnostic Techniques with PCR & NGS for CDx Combination Products
  • Comparison between Rate of Marketing of Tissue Diagnostic Techniques with PCR & NGS for Combination Products
  • Tissue and Companion Diagnostics Partnerships
  • US Capital Pricing Analysis
  • US Sales Channel Analysis
  • US Service Provider Analysis
  • US APLIS Competitor Landscape
  • US APLIS Competitor Landscape (continued)
  • US APLIS Competitor Landscape (continued)
  • US APLIS Competitor Landscape (continued)
  • US APLIS Competitor Landscape (continued)
  • US APLIS Competitor Landscape (continued)
  • US APLIS Competitor Landscape (continued)
  • US APLIS Competitor Landscape (continued)
  • US APLIS Competitor Landscape (continued)
  • US APLIS Competitor Landscape (continued)
  • Key Companies to Watch
  • Key Companies to Watch (continued)

8. WESTERN EUROPE

  • Western Europe Regional Snapshot
  • Western Europe Market Analysis
  • Western Europe Tissue Diagnostics Market Outlook
  • Western Europe Revenue Forecast
  • Western Europe Revenue Forecast Discussion
  • Western Europe Revenue Forecast Discussion (continued)
  • Western Europe Revenue Forecast Discussion (continued)
  • Western Europe Revenue Forecast Discussion (continued)
  • Western Europe Revenue Forecast Discussion (continued)
  • Western Europe Percent Revenue Forecast by Region
  • Western Europe Revenue Forecast by Region
  • Western Europe Revenue Forecast by Segment
  • Western Europe Revenue Forecast by Segment Discussion
  • UK Country Analysis
  • UK Revenue Forecast Discussion
  • Germany Country Analysis
  • Germany Revenue Forecast Discussion
  • France Country Analysis
  • France Revenue Forecast Discussion
  • Scandinavia Country Analysis
  • Scandinavia Revenue Forecast Discussion
  • Benelux Country Analysis
  • Benelux Revenue Forecast Discussion
  • Italy Country Analysis
  • Spain Country Analysis
  • Western Europe Market Share Analysis
  • Western Europe Market Share Analysis (continued)
  • Key Companies to Watch
  • Key Companies to Watch (continued)

9. APAC

  • APAC Regional Snapshot
  • APAC Market Analysis
  • APAC Tissue Diagnostics Market Outlook
  • APAC Revenue Forecast
  • APAC Revenue Forecast Discussion
  • APAC Percent Revenue Forecast by Region
  • APAC Revenue Forecast by Region
  • APAC Revenue Forecast by Segment
  • APAC Revenue Forecast by Segment Discussion
  • China Country Analysis
  • China Revenue Forecast Discussion
  • India Country Analysis
  • India Revenue Forecast Discussion
  • Japan Country Analysis
  • Japan Revenue Forecast Discussion
  • ASEAN Overall Forecast
  • ASEAN Revenue Forecast Discussion
  • Indonesia Country Analysis
  • Thailand Country Analysis
  • Singapore Country Analysis
  • Malaysia Country Analysis
  • APAC Market Share Analysis
  • APAC Market Share Analysis (continued)
  • Key Companies to Watch

10. REST OF THE WORLD (ROW)

  • ROW-Regional Snapshot
  • ROW Revenue Forecast
  • ROW Revenue Forecast by Segment
  • Revenue Forecast Discussion
  • Revenue Forecast Discussion (continued)
  • Revenue Forecast Discussion (continued)

11. LAST WORD

  • Future Trends-Three Big Predictions Driving Tissue Diagnostics Market
  • Legal Disclaimer

12. APPENDIX

  • List of Exhibits
  • List of Exhibits (continued)
  • List of Exhibits (continued)
  • List of Exhibits (continued)
  • List of Exhibits (continued)
  • List of Exhibits (continued)
  • List of Exhibits (continued)
  • Market Engineering Methodology
  • US CPT Code based Pathology Reimbursement
  • US CPT Code based Pathology Reimbursement (continued)
  • Marketed CDx Combination Products in the US-Immunohistochemistry (IHC)
  • Marketed CDx Combination Products in the US-In situ Hybridization (ISH)
  • Marketed CDx Combination Products in the US-Next Generation Sequencing (NGS)
  • Marketed CDx Combination Products in the US-Polymerase Chain Reaction (PCR)
  • US Capital Pricing Data Table
  • US Capital Pricing Data Table (continued)
  • US Capital Pricing Data Table (continued)
  • US Capital Pricing Data Table (continued)
  • US Capital Pricing Data Table (continued)
  • US Capital Pricing Data Table (continued)